Everything you need to know about Accelerated TMS for Suicidal Ideation: What the Research Shows — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Free 22-page guide — questions to ask, red flags, and how to choose the right provider.
Suicidal ideation is a psychiatric emergency. Each day of untreated suicidal thoughts carries significant risk, and the time between assessment and effective treatment represents a window of extreme vulnerability. While electroconvulsive therapy (ECT) has long been used for severe, treatment-resistant suicidal depression, it requires anesthesia, carries risks of cognitive side effects, and is not universally accessible. Transcranial magnetic stimulation, particularly in accelerated protocols, is being studied as a faster option for reducing suicidal ideation in people with depression. This research is early, and TMS is not an FDA-cleared treatment for suicidal ideation.
What You’ll Learn
- What accelerated TMS protocols are and how they differ from standard TMS
- The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol
- How TMS compares to ketamine for rapid suicidal ideation reduction
- What protocols are used in accelerated TMS research
- Important safety considerations and integration with standard psychiatric care
The Urgency of Rapid Intervention
Standard TMS protocols involve daily sessions over 6 weeks, with antidepressant effects typically emerging over weeks. For a patient in acute suicidal crisis, this timeline is unacceptable. The development of accelerated and high-dose TMS protocols has led researchers to test whether faster symptom reduction is possible.
The suicide prevention field has increasingly embraced crisis intervention models that prioritize rapid symptom reduction alongside safety planning and supportive care. TMS fits naturally into this framework, offering a biological intervention that can be deployed quickly.
Accelerated TMS Protocols for Suicidal Ideation
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)
SAINT is the best-studied accelerated protocol. Developed at Stanford University, this protocol uses:
- Accelerated iTBS (intermittent theta burst stimulation) — 10 sessions per day, each lasting approximately 10 minutes, with breaks between sessions
- 5 consecutive days of treatment (50 sessions total)
- Personalized targeting using functional connectivity MRI to identify optimal stimulation sites for each patient
- High treatment intensity — approximately 18,000 pulses per day
In the original open-label SAINT study (21 patients with treatment-resistant depression, American Journal of Psychiatry, 2020), 90.5% reached remission, and none of the participants who had suicidal thoughts at baseline reported them afterward (summary). That study had no control group. A later randomized, sham-controlled trial (Cole et al., American Journal of Psychiatry, 2022) found remission in about 78.6% of the active group vs. 13.3% with sham. SAINT (marketed as SAINT Neuromodulation Therapy) received FDA clearance in 2022 for major depression in adults who have not responded to prior antidepressant treatment, not for suicidal ideation. Research specifically in people with active suicidal ideation is ongoing.
Accelerated rTMS Protocols
Beyond SAINT, several other accelerated protocols have shown promise:
- 2 sessions per day over 2-3 weeks — produces faster response than single daily sessions
- High-dose conventional rTMS — 6-10 sessions per day using standard 10 Hz stimulation
- Clustered protocols — multiple sessions grouped in consecutive days with breaks
Evidence for these other accelerated approaches is still limited and varies by protocol.
How TMS Reduces Suicidal Ideation
The mechanisms by which TMS might affect suicidal ideation are not established. Proposed pathways include:
Reduction in depressive symptoms — Since suicidal ideation is strongly associated with depression, TMS’s antidepressant effects contribute significantly. As depression lifts, suicidal thoughts typically diminish.
Improvement in cognitive flexibility — Suicidal ideation is associated with rigid, hopelessness-laden thinking patterns. TMS to the DLPFC may influence executive function and cognitive flexibility, potentially helping patients to consider alternatives to suicide.
Decrease in pain perception — Chronic pain and emotional pain (psychache) are strongly associated with suicidal ideation. TMS has been studied for effects on pain networks, though this is speculative for suicidal ideation.
Normalization of default mode network (DMN) activity — The DMN, active during self-referential thinking, shows hyperconnectivity in suicidal individuals, potentially maintaining ruminative and hopeless thought patterns. TMS may influence DMN function.
TMS vs. Ketamine for Suicidal Ideation
Ketamine, an NMDA receptor antagonist, produces rapid (within hours) reduction in suicidal ideation and is increasingly used in psychiatric emergency settings. How does TMS compare?
Efficacy
Ketamine has a more established evidence base for rapid reduction of suicidal ideation in emergency settings, while evidence for accelerated TMS is still emerging. Ketamine’s effects can appear within hours of a single infusion, while accelerated TMS requires several days of intensive treatment.
Safety Profile
Ketamine risks:
- Dissociative symptoms during infusion
- Cardiovascular effects (elevated blood pressure, heart rate)
- Potential for abuse with repeated use
- Requires medical monitoring during infusion
TMS advantages:
- Non-invasive — no anesthesia or sedation required
- No significant cardiovascular effects
- No dissociative symptoms
- Can be administered in outpatient settings
- No known abuse potential
Practical Considerations
- Ketamine requires IV access and medical supervision
- TMS effects build cumulatively over days rather than appearing immediately
- Combination approaches (ketamine followed by TMS maintenance) are being explored
Clinical Protocols for Emergency TMS
Programs studying TMS for acute suicidal ideation generally consider:
Patient Selection
Appropriate candidates include patients with:
- Acute suicidal ideation without active psychotic features
- Inadequate response to or intolerance of standard treatments
- No contraindications to TMS (seizure disorder, metal in head, etc.)
- Ability to cooperate with multiple daily sessions
- Capacity to consent to treatment
Safety Monitoring
- Suicidal ideation assessed at each session using standardized instruments
- Constant observation between sessions for high-risk patients
- Safety planning reinforced throughout treatment
- Clear protocols for escalation of care if ideation worsens
- Coordination with psychiatry for concurrent medication management
Integration with Standard Care
TMS should never replace comprehensive psychiatric care. Optimal treatment includes:
- Concurrent psychotherapy (DBT, CBT)
- Medication optimization
- Social support intervention
- Outpatient follow-up planning
- Means restriction counseling
Current Availability
Accelerated TMS for suicidal ideation is mostly offered or studied at:
- Academic medical centers with active TMS research programs
- Specialized TMS clinics offering accelerated protocols
- Some psychiatric hospitals with neuromodulation capabilities
Access remains limited by insurance coverage and availability of trained providers; coverage of accelerated protocols varies by plan. Patients seeking this treatment may need to travel to specialized centers.
The Future
The field is moving toward:
- Further protocol optimization to maximize speed of response
- Prediction models to identify patients most likely to respond
- At-home TMS for maintenance following intensive acute treatment
- Combination protocols with ketamine, psychedelics, or novel agents
- Wider implementation through training programs and telemedicine
If You or Someone You Know Is in Crisis
TMS is not an emergency treatment and takes days to work. If you or someone you know is in immediate danger, call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room. Crisis intervention services, hospitalization when needed, and evidence-based medications remain the first-line treatments for acute suicidal crises.
*For information about TMS programs specifically addressing suicidal ideation, contact the American Psychiatric Association or search clinicaltrials.gov for active studies.
Frequently Asked Questions
Can TMS reduce suicidal thoughts quickly?
Accelerated TMS protocols, particularly the Stanford SAINT protocol, have shown rapid reductions in depression and suicidal thoughts in small studies, including an open-label study in which none of the participants with baseline suicidal thoughts reported them afterward. Larger studies in people with active suicidal ideation are ongoing, and TMS is not FDA-cleared for suicidal ideation. Standard TMS takes weeks. If you are in crisis, call or text 988.
How does TMS compare to ketamine for suicidal ideation?
Ketamine can produce effects within hours and has a more established evidence base for rapid reduction of suicidal ideation, while accelerated TMS requires several days. TMS is non-invasive, without dissociation or ketamine's cardiovascular effects. Combination approaches are being explored.
Is emergency TMS available at hospitals?
Accelerated TMS for suicidal ideation is mostly offered or studied at academic medical centers, specialized TMS clinics, and some psychiatric hospitals. It is not an emergency treatment. Access remains limited by insurance coverage and provider availability.
Ready to Explore Your TMS Options?
Browse verified TMS providers, read real reviews, and find the right treatment for your situation.
Related reading
- TMS for Multiple Sclerosis: Addressing Fatigue, Depression, and Cognitive Impairment
- What TMS Actually Feels Like: A Session-by-Session Guide
- How to Prepare for Your First TMS Session
- Preparing for Your First TMS Session: A Practical Walkthrough
- TMS for anxiety
- TMS for Treatment-Resistant Depression: What Patients Need to Know
